InvestorsHub Logo
Followers 36
Posts 2424
Boards Moderated 0
Alias Born 03/25/2009

Re: None

Wednesday, 01/18/2017 1:57:02 PM

Wednesday, January 18, 2017 1:57:02 PM

Post# of 73675
Someone please sticky the cancer research, this quote from the company, and our board of directors.

http://www.premierbiomedical.com/premier-biomedical-anti-cancer-antibody-outperforms-leading-multi-billion-dollar-commercial-cancer-treatments-initial-head-head-testing-major-university/

https://www.otcmarkets.com/stock/BIEI/news/Premier-Biomedicals-Research-on-its-Patent-Pending-Anti-Cancer-Treatment-With-Metronomic-Chemotherapy-Recognized-for-Publication-in-the-Prestigious-British-Journal-of-Cancer?id=146441&b=y

I want to reiterate the obvious for those few who believe PBI management is enriching themselves through the sale of stock:

No active board member, or member of management has sold even one share of Premier Biomedical stock.

Because we are a publicly traded company, any such sale of stock by an insider necessitates immediate public disclosure through the SEC. Moreover, no active member of PBI management has received one penny in compensation for services rendered.

There are no financial bonuses or company cars for any member of management.

All members of management, including board members, have contributed considerable sums of money, time and effort toward the success of this company.

Their only compensation is by receipt of stock warrants priced significantly higher than the current market, thus giving them incentive to insure the success of the company.

http://www.premierbiomedical.com/premier-biomedical-inc-ceo-letter-december-2017/




http://www.premierbiomedical.com/about/our-team/

Note: Patricio F. Reyes, MD, FAAN our chief technical Officer is the Chief medical officer of the Retired NFL PLayers Association


http://www.nflretiredplayersassociation.org/board-of-directors.html